

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.68552380 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.33089604 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.33089604 |
| 4 | respiratory electron transport chain (GO:0022904) | 5.26341290 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.17630094 |
| 6 | electron transport chain (GO:0022900) | 5.13009532 |
| 7 | oxidative phosphorylation (GO:0006119) | 4.78922207 |
| 8 | protein deneddylation (GO:0000338) | 4.74551817 |
| 9 | cullin deneddylation (GO:0010388) | 4.74424856 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 4.72707469 |
| 11 | proteasome assembly (GO:0043248) | 4.70699653 |
| 12 | protein complex biogenesis (GO:0070271) | 4.36041682 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.33778308 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 4.33778308 |
| 15 | branched-chain amino acid catabolic process (GO:0009083) | 4.30096857 |
| 16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.23568056 |
| 17 | NADH dehydrogenase complex assembly (GO:0010257) | 4.23568056 |
| 18 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.23568056 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 4.15581194 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.15581194 |
| 21 | respiratory chain complex IV assembly (GO:0008535) | 4.14056522 |
| 22 | fatty acid beta-oxidation (GO:0006635) | 4.06254580 |
| 23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.00658552 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.99215757 |
| 25 | valine metabolic process (GO:0006573) | 3.98865913 |
| 26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.93186851 |
| 27 | succinate metabolic process (GO:0006105) | 3.92799392 |
| 28 | branched-chain amino acid metabolic process (GO:0009081) | 3.85853207 |
| 29 | aerobic respiration (GO:0009060) | 3.81518967 |
| 30 | inner mitochondrial membrane organization (GO:0007007) | 3.80715892 |
| 31 | lysine metabolic process (GO:0006553) | 3.77684277 |
| 32 | lysine catabolic process (GO:0006554) | 3.77684277 |
| 33 | NADH metabolic process (GO:0006734) | 3.75047704 |
| 34 | fatty acid catabolic process (GO:0009062) | 3.72831800 |
| 35 | ubiquinone biosynthetic process (GO:0006744) | 3.71222938 |
| 36 | quinone biosynthetic process (GO:1901663) | 3.71222938 |
| 37 | cytochrome complex assembly (GO:0017004) | 3.69099836 |
| 38 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.67884228 |
| 39 | short-chain fatty acid metabolic process (GO:0046459) | 3.65750427 |
| 40 | platelet dense granule organization (GO:0060155) | 3.65262807 |
| 41 | ribosomal small subunit assembly (GO:0000028) | 3.63759716 |
| 42 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.62938748 |
| 43 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.62938748 |
| 44 | lipid oxidation (GO:0034440) | 3.62494341 |
| 45 | fatty acid oxidation (GO:0019395) | 3.62298370 |
| 46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.61647871 |
| 47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.61621260 |
| 48 | daunorubicin metabolic process (GO:0044597) | 3.59280311 |
| 49 | polyketide metabolic process (GO:0030638) | 3.59280311 |
| 50 | doxorubicin metabolic process (GO:0044598) | 3.59280311 |
| 51 | positive regulation of mitochondrial fission (GO:0090141) | 3.59081672 |
| 52 | DNA deamination (GO:0045006) | 3.58210818 |
| 53 | tricarboxylic acid metabolic process (GO:0072350) | 3.57837420 |
| 54 | protein neddylation (GO:0045116) | 3.54756403 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53251136 |
| 56 | regulation of cofactor metabolic process (GO:0051193) | 3.51615765 |
| 57 | regulation of coenzyme metabolic process (GO:0051196) | 3.51615765 |
| 58 | chaperone-mediated protein transport (GO:0072321) | 3.46176269 |
| 59 | oxaloacetate metabolic process (GO:0006107) | 3.42393082 |
| 60 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.41954595 |
| 61 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.41917689 |
| 62 | base-excision repair, AP site formation (GO:0006285) | 3.41779320 |
| 63 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.41208090 |
| 64 | glyoxylate metabolic process (GO:0046487) | 3.40945745 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.38937543 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.38512253 |
| 67 | carnitine metabolic process (GO:0009437) | 3.35751179 |
| 68 | regulation of mitochondrial translation (GO:0070129) | 3.34033177 |
| 69 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.33634293 |
| 70 | protein targeting to mitochondrion (GO:0006626) | 3.33437678 |
| 71 | heart process (GO:0003015) | 3.30012993 |
| 72 | heart contraction (GO:0060047) | 3.30012993 |
| 73 | aromatic amino acid family catabolic process (GO:0009074) | 3.27926527 |
| 74 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.27679432 |
| 75 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.27049654 |
| 76 | negative regulation of ligase activity (GO:0051352) | 3.24196142 |
| 77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.24196142 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23572016 |
| 79 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.20108682 |
| 80 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.19891368 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 3.17095047 |
| 82 | ATP biosynthetic process (GO:0006754) | 3.15020767 |
| 83 | amino-acid betaine metabolic process (GO:0006577) | 3.14086599 |
| 84 | deoxyribose phosphate catabolic process (GO:0046386) | 3.13588819 |
| 85 | ubiquinone metabolic process (GO:0006743) | 3.12141528 |
| 86 | * GPI anchor biosynthetic process (GO:0006506) | 3.11491229 |
| 87 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.11365151 |
| 88 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.08644608 |
| 89 | termination of RNA polymerase III transcription (GO:0006386) | 3.08644608 |
| 90 | protein localization to mitochondrion (GO:0070585) | 3.08578098 |
| 91 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.07384531 |
| 92 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.07384531 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.07096011 |
| 94 | establishment of protein localization to mitochondrion (GO:0072655) | 3.06860852 |
| 95 | cellular respiration (GO:0045333) | 3.06624803 |
| 96 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06374688 |
| 97 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06374688 |
| 98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06374688 |
| 99 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.06276101 |
| 100 | ketone body metabolic process (GO:1902224) | 3.04228331 |
| 101 | deoxyribonucleotide catabolic process (GO:0009264) | 3.02896981 |
| 102 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.99721920 |
| 103 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.99721920 |
| 104 | metallo-sulfur cluster assembly (GO:0031163) | 2.98424698 |
| 105 | iron-sulfur cluster assembly (GO:0016226) | 2.98424698 |
| 106 | peptidyl-histidine modification (GO:0018202) | 2.98418539 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 2.96366844 |
| 108 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.95432909 |
| 109 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.94069737 |
| 110 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.93871058 |
| 111 | C-terminal protein lipidation (GO:0006501) | 2.93621302 |
| 112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93171944 |
| 113 | * GPI anchor metabolic process (GO:0006505) | 2.91285403 |
| 114 | positive regulation of prostaglandin secretion (GO:0032308) | 2.90643270 |
| 115 | protein-cofactor linkage (GO:0018065) | 2.90535367 |
| 116 | protein maturation by protein folding (GO:0022417) | 2.90458339 |
| 117 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.89400058 |
| 118 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.89400058 |
| 119 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89383910 |
| 120 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.88314163 |
| 121 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.88266666 |
| 122 | organic acid catabolic process (GO:0016054) | 2.88061560 |
| 123 | carboxylic acid catabolic process (GO:0046395) | 2.88061560 |
| 124 | regulation of relaxation of muscle (GO:1901077) | 2.87488582 |
| 125 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.87321915 |
| 126 | NAD metabolic process (GO:0019674) | 2.86567853 |
| 127 | regulation of sulfur metabolic process (GO:0042762) | 2.85875060 |
| 128 | alpha-linolenic acid metabolic process (GO:0036109) | 2.85681231 |
| 129 | homocysteine metabolic process (GO:0050667) | 2.84261497 |
| 130 | regulation of oxidative phosphorylation (GO:0002082) | 2.82764512 |
| 131 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.82700442 |
| 132 | coenzyme catabolic process (GO:0009109) | 2.81991327 |
| 133 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81874877 |
| 134 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.81521841 |
| 135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.80892651 |
| 136 | ribonucleoprotein complex disassembly (GO:0032988) | 2.80879583 |
| 137 | deoxyribose phosphate metabolic process (GO:0019692) | 2.80664630 |
| 138 | sulfur amino acid catabolic process (GO:0000098) | 2.79214470 |
| 139 | regulation of cilium movement (GO:0003352) | 2.78938938 |
| 140 | quinone metabolic process (GO:1901661) | 2.78418540 |
| 141 | positive regulation of ligase activity (GO:0051351) | 2.77078535 |
| 142 | tryptophan metabolic process (GO:0006568) | 2.76486966 |
| 143 | regulation of cholesterol esterification (GO:0010872) | 2.74484041 |
| 144 | hydrogen ion transmembrane transport (GO:1902600) | 2.74414097 |
| 145 | aldehyde catabolic process (GO:0046185) | 2.74380557 |
| 146 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.73038907 |
| 147 | indole-containing compound catabolic process (GO:0042436) | 2.71628227 |
| 148 | indolalkylamine catabolic process (GO:0046218) | 2.71628227 |
| 149 | tryptophan catabolic process (GO:0006569) | 2.71628227 |
| 150 | alpha-amino acid catabolic process (GO:1901606) | 2.71093403 |
| 151 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.70963890 |
| 152 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.70963890 |
| 153 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.70301212 |
| 154 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.70060928 |
| 155 | regulation of cellular amine metabolic process (GO:0033238) | 2.69956439 |
| 156 | bile acid biosynthetic process (GO:0006699) | 2.69757234 |
| 157 | organelle disassembly (GO:1903008) | 2.69393901 |
| 158 | regulation of triglyceride catabolic process (GO:0010896) | 2.69335406 |
| 159 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.68666815 |
| 160 | DNA damage response, detection of DNA damage (GO:0042769) | 2.68257007 |
| 161 | polyamine metabolic process (GO:0006595) | 2.68076905 |
| 162 | nucleotide transmembrane transport (GO:1901679) | 2.66724212 |
| 163 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.66336235 |
| 164 | signal peptide processing (GO:0006465) | 2.66022384 |
| 165 | cellular amino acid catabolic process (GO:0009063) | 2.65999991 |
| 166 | acyl-CoA metabolic process (GO:0006637) | 2.65458150 |
| 167 | thioester metabolic process (GO:0035383) | 2.65458150 |
| 168 | kynurenine metabolic process (GO:0070189) | 2.64376714 |
| 169 | proton transport (GO:0015992) | 2.64362622 |
| 170 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.62999447 |
| 171 | biotin metabolic process (GO:0006768) | 2.61641921 |
| 172 | L-methionine salvage (GO:0071267) | 2.60915730 |
| 173 | L-methionine biosynthetic process (GO:0071265) | 2.60915730 |
| 174 | amino acid salvage (GO:0043102) | 2.60915730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.70636132 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.50836816 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.50232268 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49912467 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.29715228 |
| 6 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 3.27023720 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.18119292 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.09190033 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.07822465 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.05280090 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.04476770 |
| 12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.03438019 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.90356067 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.89647057 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.78296735 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.72262473 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.54083601 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.44487269 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.42129722 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40088062 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.33870814 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31280707 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.26234858 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.18605961 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11279090 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09717018 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.02100451 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01217710 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.98636568 |
| 30 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.98463599 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96305574 |
| 32 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.92997567 |
| 33 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92290277 |
| 34 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.91534549 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85882386 |
| 36 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.81896268 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72913480 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66809076 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63226757 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.63008638 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61527499 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61028389 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.60957712 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59152402 |
| 45 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.57495398 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.52950298 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52722787 |
| 48 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51310295 |
| 49 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.49478384 |
| 50 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.45519242 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44661297 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44658601 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40146009 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38298615 |
| 55 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38145109 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36514231 |
| 57 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34237138 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32249338 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32025994 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31378521 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27282332 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26092868 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.23963027 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21022482 |
| 65 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16765520 |
| 66 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16590942 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14184389 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11737477 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10902592 |
| 70 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.10454148 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09595750 |
| 72 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09590502 |
| 73 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09273198 |
| 74 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.09128320 |
| 75 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07537792 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07084792 |
| 77 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06920770 |
| 78 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06551340 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06037672 |
| 80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04410633 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03042468 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02244588 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00792218 |
| 84 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00578112 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00504385 |
| 86 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99821143 |
| 87 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98950974 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98733865 |
| 89 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98011038 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97895296 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96153739 |
| 92 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94609467 |
| 93 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94443018 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93799857 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93372849 |
| 96 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.93364576 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92961818 |
| 98 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92959990 |
| 99 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.92257411 |
| 100 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92111651 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91108578 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91053354 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90273182 |
| 104 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.90259735 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.90259735 |
| 106 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89313008 |
| 107 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89281302 |
| 108 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87744716 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.86841049 |
| 110 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86699527 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86609084 |
| 112 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.86531967 |
| 113 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86433309 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85288257 |
| 115 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.85275329 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.84626757 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84345197 |
| 118 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.84299130 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84069656 |
| 120 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.83664975 |
| 121 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.82586393 |
| 122 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.80896248 |
| 123 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80620742 |
| 124 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.80549349 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79961391 |
| 126 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.79242322 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78749056 |
| 128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77251251 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76415614 |
| 130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.75817311 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75264924 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74273263 |
| 133 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.73851109 |
| 134 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.71555365 |
| 135 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.70210773 |
| 136 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.70178052 |
| 137 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69627523 |
| 138 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.67254646 |
| 139 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.67244075 |
| 140 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.65214250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.47355316 |
| 2 | MP0005360_urolithiasis | 3.73365399 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.65938634 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.47517505 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.32948433 |
| 6 | MP0005365_abnormal_bile_salt | 3.29177637 |
| 7 | MP0006036_abnormal_mitochondrial_physio | 3.22815210 |
| 8 | MP0003646_muscle_fatigue | 3.16158954 |
| 9 | MP0001529_abnormal_vocalization | 3.05483483 |
| 10 | MP0000749_muscle_degeneration | 2.86510108 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75674246 |
| 12 | MP0005332_abnormal_amino_acid | 2.68893812 |
| 13 | MP0009697_abnormal_copulation | 2.54788450 |
| 14 | MP0003195_calcinosis | 2.53591301 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.48579842 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 2.37448476 |
| 17 | MP0004043_abnormal_pH_regulation | 2.37304921 |
| 18 | MP0002102_abnormal_ear_morphology | 2.36752361 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.29488825 |
| 20 | MP0003186_abnormal_redox_activity | 2.25845163 |
| 21 | MP0008058_abnormal_DNA_repair | 2.21245415 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.16415913 |
| 23 | MP0003786_premature_aging | 2.16378908 |
| 24 | MP0004036_abnormal_muscle_relaxation | 2.06880402 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 2.03181369 |
| 26 | MP0005330_cardiomyopathy | 1.98328601 |
| 27 | MP0000751_myopathy | 1.97919722 |
| 28 | MP0001764_abnormal_homeostasis | 1.94012900 |
| 29 | MP0008789_abnormal_olfactory_epithelium | 1.93463089 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.92451723 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.86091687 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.80451920 |
| 33 | MP0001905_abnormal_dopamine_level | 1.76809429 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.75295296 |
| 35 | MP0005671_abnormal_response_to | 1.73420934 |
| 36 | MP0003880_abnormal_central_pattern | 1.72923500 |
| 37 | MP0002090_abnormal_vision | 1.71402955 |
| 38 | MP0009785_altered_susceptibility_to | 1.67588583 |
| 39 | MP0001984_abnormal_olfaction | 1.67461139 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.67161872 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.67035574 |
| 42 | MP0004147_increased_porphyrin_level | 1.66132475 |
| 43 | MP0005083_abnormal_biliary_tract | 1.65308992 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.63487447 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.62604314 |
| 46 | MP0008775_abnormal_heart_ventricle | 1.61076324 |
| 47 | MP0005253_abnormal_eye_physiology | 1.58256809 |
| 48 | MP0004130_abnormal_muscle_cell | 1.57653664 |
| 49 | MP0009840_abnormal_foam_cell | 1.55286829 |
| 50 | MP0002095_abnormal_skin_pigmentation | 1.53503611 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.52580154 |
| 52 | MP0003252_abnormal_bile_duct | 1.51346055 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.48599517 |
| 54 | MP0003011_delayed_dark_adaptation | 1.46919551 |
| 55 | MP0009046_muscle_twitch | 1.46449106 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.46061576 |
| 57 | MP0004142_abnormal_muscle_tone | 1.44689634 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.43544401 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.41366565 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.41361802 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.38528420 |
| 62 | MP0005620_abnormal_muscle_contractility | 1.37121709 |
| 63 | MP0005670_abnormal_white_adipose | 1.31149837 |
| 64 | MP0002736_abnormal_nociception_after | 1.28899993 |
| 65 | MP0003137_abnormal_impulse_conducting | 1.27823659 |
| 66 | MP0001853_heart_inflammation | 1.26901020 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 1.26148891 |
| 68 | MP0001542_abnormal_bone_strength | 1.25819379 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.23755631 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.23150607 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.23056813 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.22654243 |
| 73 | MP0002269_muscular_atrophy | 1.21638280 |
| 74 | MP0000230_abnormal_systemic_arterial | 1.20451538 |
| 75 | MP0005394_taste/olfaction_phenotype | 1.19689232 |
| 76 | MP0005499_abnormal_olfactory_system | 1.19689232 |
| 77 | MP0001544_abnormal_cardiovascular_syste | 1.19414851 |
| 78 | MP0005385_cardiovascular_system_phenoty | 1.19414851 |
| 79 | MP0005535_abnormal_body_temperature | 1.18763891 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.18196558 |
| 81 | MP0004087_abnormal_muscle_fiber | 1.17138863 |
| 82 | MP0000609_abnormal_liver_physiology | 1.15320352 |
| 83 | MP0000358_abnormal_cell_content/ | 1.15020168 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14755010 |
| 85 | MP0001968_abnormal_touch/_nociception | 1.10987707 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 1.10262345 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 1.09589425 |
| 88 | MP0000516_abnormal_urinary_system | 1.09589425 |
| 89 | MP0005266_abnormal_metabolism | 1.09519326 |
| 90 | MP0002127_abnormal_cardiovascular_syste | 1.09224543 |
| 91 | MP0005171_absent_coat_pigmentation | 1.07771356 |
| 92 | MP0002876_abnormal_thyroid_physiology | 1.07731949 |
| 93 | MP0003868_abnormal_feces_composition | 1.06946974 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 1.05525466 |
| 95 | MP0002106_abnormal_muscle_physiology | 1.04626269 |
| 96 | MP0003718_maternal_effect | 1.04399954 |
| 97 | MP0001501_abnormal_sleep_pattern | 1.03575553 |
| 98 | MP0005389_reproductive_system_phenotype | 1.03324370 |
| 99 | MP0002971_abnormal_brown_adipose | 1.02269566 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 1.02193073 |
| 101 | MP0000647_abnormal_sebaceous_gland | 1.01882864 |
| 102 | MP0002272_abnormal_nervous_system | 1.01454503 |
| 103 | MP0001919_abnormal_reproductive_system | 1.00998675 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.99805600 |
| 105 | MP0003724_increased_susceptibility_to | 0.99023725 |
| 106 | MP0001188_hyperpigmentation | 0.96024624 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.95959754 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.95934527 |
| 109 | MP0001727_abnormal_embryo_implantation | 0.95315595 |
| 110 | MP0003191_abnormal_cellular_cholesterol | 0.94220603 |
| 111 | MP0008469_abnormal_protein_level | 0.92834173 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.91859768 |
| 113 | MP0004085_abnormal_heartbeat | 0.91213418 |
| 114 | MP0008872_abnormal_physiological_respon | 0.88738047 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.88609363 |
| 116 | MP0002160_abnormal_reproductive_system | 0.88466987 |
| 117 | MP0010094_abnormal_chromosome_stability | 0.87273596 |
| 118 | MP0009642_abnormal_blood_homeostasis | 0.86869543 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.86758032 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.84949333 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.84537201 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.84389738 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.84157742 |
| 124 | MP0010630_abnormal_cardiac_muscle | 0.83469919 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.83000810 |
| 126 | MP0006276_abnormal_autonomic_nervous | 0.82685663 |
| 127 | MP0006082_CNS_inflammation | 0.82625960 |
| 128 | MP0003279_aneurysm | 0.82586280 |
| 129 | MP0000747_muscle_weakness | 0.82447706 |
| 130 | MP0008995_early_reproductive_senescence | 0.81665537 |
| 131 | MP0005000_abnormal_immune_tolerance | 0.80445433 |
| 132 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79558466 |
| 133 | MP0002723_abnormal_immune_serum | 0.79279056 |
| 134 | MP0003787_abnormal_imprinting | 0.79226674 |
| 135 | MP0006054_spinal_hemorrhage | 0.79166131 |
| 136 | MP0000343_altered_response_to | 0.77420113 |
| 137 | MP0005369_muscle_phenotype | 0.76614171 |
| 138 | MP0005408_hypopigmentation | 0.75859128 |
| 139 | MP0000427_abnormal_hair_cycle | 0.75118656 |
| 140 | MP0004484_altered_response_of | 0.74448291 |
| 141 | MP0008932_abnormal_embryonic_tissue | 0.74041473 |
| 142 | MP0001756_abnormal_urination | 0.73601454 |
| 143 | MP0006138_congestive_heart_failure | 0.72769141 |
| 144 | MP0001879_abnormal_lymphatic_vessel | 0.71812405 |
| 145 | MP0005075_abnormal_melanosome_morpholog | 0.71350809 |
| 146 | MP0000598_abnormal_liver_morphology | 0.71294781 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.70970976 |
| 148 | MP0002693_abnormal_pancreas_physiology | 0.70769707 |
| 149 | MP0009745_abnormal_behavioral_response | 0.70433157 |
| 150 | MP0000759_abnormal_skeletal_muscle | 0.69759616 |
| 151 | MP0005167_abnormal_blood-brain_barrier | 0.69756304 |
| 152 | MP0002452_abnormal_antigen_presenting | 0.68962092 |
| 153 | MP0005646_abnormal_pituitary_gland | 0.68209203 |
| 154 | MP0009764_decreased_sensitivity_to | 0.68174953 |
| 155 | MP0005187_abnormal_penis_morphology | 0.67949141 |
| 156 | MP0001944_abnormal_pancreas_morphology | 0.67705581 |
| 157 | MP0001502_abnormal_circadian_rhythm | 0.66387592 |
| 158 | MP0001800_abnormal_humoral_immune | 0.66191497 |
| 159 | MP0001845_abnormal_inflammatory_respons | 0.65382129 |
| 160 | MP0001324_abnormal_eye_pigmentation | 0.64512505 |
| 161 | MP0003136_yellow_coat_color | 0.63834746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 5.32733383 |
| 2 | Hepatocellular necrosis (HP:0001404) | 4.92986135 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.56097615 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.55343599 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.39735525 |
| 6 | Increased muscle lipid content (HP:0009058) | 4.35132482 |
| 7 | Increased intramyocellular lipid droplets (HP:0012240) | 4.31066246 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.20884534 |
| 9 | Acute encephalopathy (HP:0006846) | 4.18060991 |
| 10 | Increased CSF lactate (HP:0002490) | 4.17790287 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14020629 |
| 12 | Generalized aminoaciduria (HP:0002909) | 4.01020392 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.00600236 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.00600236 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.97416035 |
| 16 | Lactic acidosis (HP:0003128) | 3.83574460 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.77452223 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 3.77452223 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.74515335 |
| 20 | Myoglobinuria (HP:0002913) | 3.74410513 |
| 21 | Cerebral edema (HP:0002181) | 3.73726418 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.73449296 |
| 23 | Ketoacidosis (HP:0001993) | 3.70398570 |
| 24 | Progressive macrocephaly (HP:0004481) | 3.63653310 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.48014444 |
| 26 | Ketosis (HP:0001946) | 3.44739181 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 3.43678235 |
| 28 | Increased serum lactate (HP:0002151) | 3.34720064 |
| 29 | Exercise intolerance (HP:0003546) | 3.31056314 |
| 30 | Hyperammonemia (HP:0001987) | 3.10145547 |
| 31 | Glycosuria (HP:0003076) | 3.09693332 |
| 32 | Abnormality of urine glucose concentration (HP:0011016) | 3.09693332 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 3.09657936 |
| 34 | Ragged-red muscle fibers (HP:0003200) | 3.08712206 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.02104386 |
| 36 | Palpitations (HP:0001962) | 3.00401847 |
| 37 | Lethargy (HP:0001254) | 2.99652987 |
| 38 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.98355023 |
| 39 | Abnormality of alanine metabolism (HP:0010916) | 2.98355023 |
| 40 | Hyperalaninemia (HP:0003348) | 2.98355023 |
| 41 | Congenital primary aphakia (HP:0007707) | 2.96963359 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.93055686 |
| 43 | Respiratory failure (HP:0002878) | 2.92728934 |
| 44 | Gait imbalance (HP:0002141) | 2.84979651 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.84361625 |
| 46 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.84297589 |
| 47 | Hyperglycinuria (HP:0003108) | 2.84003809 |
| 48 | Abnormality of glycolysis (HP:0004366) | 2.82848487 |
| 49 | Increased serum pyruvate (HP:0003542) | 2.82848487 |
| 50 | 3-Methylglutaconic aciduria (HP:0003535) | 2.81908006 |
| 51 | Proximal tubulopathy (HP:0000114) | 2.81020019 |
| 52 | Exertional dyspnea (HP:0002875) | 2.80469548 |
| 53 | Renal cortical cysts (HP:0000803) | 2.80460171 |
| 54 | Exercise-induced myalgia (HP:0003738) | 2.80335723 |
| 55 | Prolonged partial thromboplastin time (HP:0003645) | 2.72991855 |
| 56 | Degeneration of anterior horn cells (HP:0002398) | 2.69105513 |
| 57 | Abnormality of the anterior horn cell (HP:0006802) | 2.69105513 |
| 58 | Late onset (HP:0003584) | 2.68049689 |
| 59 | Respiratory difficulties (HP:0002880) | 2.64080247 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.62332293 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.62332293 |
| 62 | Metabolic acidosis (HP:0001942) | 2.61127358 |
| 63 | Microvesicular hepatic steatosis (HP:0001414) | 2.54126097 |
| 64 | Exercise-induced muscle cramps (HP:0003710) | 2.52880992 |
| 65 | Emotional lability (HP:0000712) | 2.42845770 |
| 66 | Optic disc pallor (HP:0000543) | 2.42435689 |
| 67 | CNS demyelination (HP:0007305) | 2.40889389 |
| 68 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.40659483 |
| 69 | Abnormality of renal resorption (HP:0011038) | 2.40210290 |
| 70 | Methylmalonic aciduria (HP:0012120) | 2.39356268 |
| 71 | Retinal dysplasia (HP:0007973) | 2.38087858 |
| 72 | Hyperglycinemia (HP:0002154) | 2.37676203 |
| 73 | Hyperphosphaturia (HP:0003109) | 2.36963238 |
| 74 | Hypothermia (HP:0002045) | 2.35874500 |
| 75 | Vomiting (HP:0002013) | 2.31212231 |
| 76 | Short tibia (HP:0005736) | 2.26852035 |
| 77 | Metaphyseal dysplasia (HP:0100255) | 2.26127767 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 2.25150505 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.24795007 |
| 80 | Dilated cardiomyopathy (HP:0001644) | 2.23883202 |
| 81 | Hyperlipoproteinemia (HP:0010980) | 2.22224006 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.20815956 |
| 83 | Xanthomatosis (HP:0000991) | 2.19771348 |
| 84 | Nausea (HP:0002018) | 2.19429794 |
| 85 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15625454 |
| 86 | Hyperbilirubinemia (HP:0002904) | 2.13767709 |
| 87 | Calf muscle hypertrophy (HP:0008981) | 2.13679969 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.12544486 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07635898 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.04417900 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 2.04219604 |
| 92 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.03676886 |
| 93 | Sudden death (HP:0001699) | 2.02981386 |
| 94 | Methylmalonic acidemia (HP:0002912) | 2.02678027 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01800339 |
| 96 | Lipoatrophy (HP:0100578) | 2.00938508 |
| 97 | Hypobetalipoproteinemia (HP:0003563) | 1.99884542 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 1.99570907 |
| 99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99194579 |
| 100 | Abnormal urine phosphate concentration (HP:0012599) | 1.98921446 |
| 101 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.98528160 |
| 102 | Hypoglycemic seizures (HP:0002173) | 1.97019259 |
| 103 | Spastic paraparesis (HP:0002313) | 1.95478336 |
| 104 | Conjunctival hamartoma (HP:0100780) | 1.95151059 |
| 105 | Abnormal protein glycosylation (HP:0012346) | 1.92649786 |
| 106 | Abnormal glycosylation (HP:0012345) | 1.92649786 |
| 107 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92649786 |
| 108 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92649786 |
| 109 | IgG deficiency (HP:0004315) | 1.92131193 |
| 110 | Cerebral hypomyelination (HP:0006808) | 1.89774715 |
| 111 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.89535672 |
| 112 | Central scotoma (HP:0000603) | 1.89483043 |
| 113 | Renal tubular dysfunction (HP:0000124) | 1.89453873 |
| 114 | Opisthotonus (HP:0002179) | 1.88974283 |
| 115 | Progressive microcephaly (HP:0000253) | 1.88857617 |
| 116 | Leukodystrophy (HP:0002415) | 1.87903883 |
| 117 | Molar tooth sign on MRI (HP:0002419) | 1.87603006 |
| 118 | Abnormality of midbrain morphology (HP:0002418) | 1.87603006 |
| 119 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.87361632 |
| 120 | Brushfield spots (HP:0001088) | 1.86544590 |
| 121 | Hypoplasia of the uterus (HP:0000013) | 1.85870270 |
| 122 | Muscle stiffness (HP:0003552) | 1.84655024 |
| 123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84293094 |
| 124 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81544607 |
| 125 | True hermaphroditism (HP:0010459) | 1.79010522 |
| 126 | Abnormality of the prostate (HP:0008775) | 1.75355188 |
| 127 | Genital tract atresia (HP:0001827) | 1.75078272 |
| 128 | Amyotrophic lateral sclerosis (HP:0007354) | 1.74655518 |
| 129 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.73099928 |
| 130 | Vaginal atresia (HP:0000148) | 1.71699743 |
| 131 | Vacuolated lymphocytes (HP:0001922) | 1.71505022 |
| 132 | X-linked dominant inheritance (HP:0001423) | 1.69486691 |
| 133 | Delusions (HP:0000746) | 1.68895824 |
| 134 | Polyphagia (HP:0002591) | 1.68349338 |
| 135 | CNS hypomyelination (HP:0003429) | 1.67832905 |
| 136 | Broad foot (HP:0001769) | 1.67105173 |
| 137 | Abnormality of vitamin B metabolism (HP:0004340) | 1.66840510 |
| 138 | Blindness (HP:0000618) | 1.65299262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.29662219 |
| 2 | MUSK | 3.80866425 |
| 3 | FLT3 | 3.07306580 |
| 4 | PBK | 3.03909641 |
| 5 | OBSCN | 3.03722260 |
| 6 | MAP4K2 | 2.98436563 |
| 7 | TESK2 | 2.90588315 |
| 8 | MYLK | 2.78024645 |
| 9 | INSRR | 2.77172871 |
| 10 | ERBB3 | 2.68950907 |
| 11 | STK16 | 2.47960253 |
| 12 | TESK1 | 2.43773477 |
| 13 | PHKG1 | 2.40568025 |
| 14 | PHKG2 | 2.40568025 |
| 15 | CSNK1G3 | 2.39835103 |
| 16 | LMTK2 | 2.39318492 |
| 17 | NME2 | 2.35949008 |
| 18 | TRIM28 | 2.22555797 |
| 19 | PIK3CG | 2.20877917 |
| 20 | BCR | 2.19302079 |
| 21 | CSNK1G2 | 2.08104056 |
| 22 | NME1 | 2.00612578 |
| 23 | TNIK | 1.97511239 |
| 24 | CSNK1A1L | 1.92379737 |
| 25 | CSNK1G1 | 1.80522794 |
| 26 | MAP3K4 | 1.71237983 |
| 27 | TAOK3 | 1.69252538 |
| 28 | VRK2 | 1.67262419 |
| 29 | MST4 | 1.67080119 |
| 30 | PINK1 | 1.61090088 |
| 31 | ARAF | 1.57837118 |
| 32 | EIF2AK3 | 1.47093783 |
| 33 | NUAK1 | 1.45564313 |
| 34 | FRK | 1.38839854 |
| 35 | CAMKK2 | 1.36428320 |
| 36 | STK38L | 1.35062789 |
| 37 | PIK3CA | 1.32236591 |
| 38 | TEC | 1.31996926 |
| 39 | PDK3 | 1.27983678 |
| 40 | PDK4 | 1.27983678 |
| 41 | BRSK2 | 1.27794724 |
| 42 | DAPK1 | 1.26786128 |
| 43 | MAP2K7 | 1.26104477 |
| 44 | IRAK3 | 1.25891026 |
| 45 | WNK4 | 1.18040636 |
| 46 | PKN2 | 1.14712519 |
| 47 | KDR | 1.09967457 |
| 48 | TLK1 | 1.09763919 |
| 49 | ZAK | 1.05909107 |
| 50 | STK24 | 1.04241794 |
| 51 | ADRBK2 | 1.03549260 |
| 52 | PRKG2 | 1.02869747 |
| 53 | KIT | 1.02061300 |
| 54 | BUB1 | 0.99172742 |
| 55 | VRK1 | 0.95732399 |
| 56 | ERN1 | 0.95713254 |
| 57 | IRAK2 | 0.94651944 |
| 58 | CDK8 | 0.93961274 |
| 59 | PDK2 | 0.92859292 |
| 60 | NEK1 | 0.92738822 |
| 61 | MAPKAPK5 | 0.92012717 |
| 62 | EIF2AK1 | 0.89690675 |
| 63 | TIE1 | 0.86030697 |
| 64 | MAPK11 | 0.85992617 |
| 65 | IRAK1 | 0.84074461 |
| 66 | PRKAA2 | 0.82993503 |
| 67 | MINK1 | 0.82292887 |
| 68 | CCNB1 | 0.80622106 |
| 69 | MAP2K6 | 0.80168757 |
| 70 | SRPK1 | 0.77545282 |
| 71 | CAMK2D | 0.75802592 |
| 72 | RPS6KA4 | 0.75335633 |
| 73 | TTN | 0.73402985 |
| 74 | TBK1 | 0.73118225 |
| 75 | BMPR1B | 0.72833766 |
| 76 | BTK | 0.72772629 |
| 77 | MAP3K5 | 0.72012212 |
| 78 | CAMK1 | 0.71420998 |
| 79 | CAMK2G | 0.71180446 |
| 80 | MAP2K3 | 0.69727484 |
| 81 | SIK3 | 0.67297257 |
| 82 | CDK19 | 0.67257020 |
| 83 | ABL2 | 0.65053562 |
| 84 | PIM2 | 0.65022325 |
| 85 | SCYL2 | 0.64717634 |
| 86 | GRK7 | 0.64283496 |
| 87 | DAPK3 | 0.63617013 |
| 88 | DYRK2 | 0.62479495 |
| 89 | IKBKB | 0.60686384 |
| 90 | MAP3K6 | 0.60228284 |
| 91 | TGFBR1 | 0.59717085 |
| 92 | WNK3 | 0.58898270 |
| 93 | GRK6 | 0.58438343 |
| 94 | MAP3K12 | 0.58128708 |
| 95 | PLK2 | 0.57655684 |
| 96 | DYRK3 | 0.55857658 |
| 97 | FES | 0.53299772 |
| 98 | PRKCE | 0.52004785 |
| 99 | PLK4 | 0.51469009 |
| 100 | TXK | 0.51229960 |
| 101 | MAPK12 | 0.51052974 |
| 102 | ILK | 0.50683266 |
| 103 | RAF1 | 0.50428793 |
| 104 | CDK14 | 0.49366669 |
| 105 | IRAK4 | 0.49341523 |
| 106 | MKNK1 | 0.48684415 |
| 107 | PLK1 | 0.48412849 |
| 108 | BLK | 0.48224305 |
| 109 | MAPK4 | 0.47841321 |
| 110 | DAPK2 | 0.47066436 |
| 111 | CSNK1A1 | 0.47000624 |
| 112 | CAMK4 | 0.46645163 |
| 113 | GRK1 | 0.46611766 |
| 114 | ZAP70 | 0.45296898 |
| 115 | NEK9 | 0.45286959 |
| 116 | EIF2AK2 | 0.45028032 |
| 117 | PLK3 | 0.44879839 |
| 118 | PRKAA1 | 0.44422412 |
| 119 | PASK | 0.43962985 |
| 120 | IKBKE | 0.41397570 |
| 121 | MAPKAPK3 | 0.41026743 |
| 122 | MST1R | 0.40393528 |
| 123 | MAPK15 | 0.40126878 |
| 124 | PRKACA | 0.39933613 |
| 125 | BRSK1 | 0.39715732 |
| 126 | MKNK2 | 0.39446321 |
| 127 | AURKB | 0.39086274 |
| 128 | CSF1R | 0.38644378 |
| 129 | LIMK1 | 0.38367984 |
| 130 | DYRK1B | 0.37758963 |
| 131 | BMPR2 | 0.37723049 |
| 132 | AURKA | 0.37217175 |
| 133 | MAP2K4 | 0.36958887 |
| 134 | SIK1 | 0.36584112 |
| 135 | CSNK2A2 | 0.35811763 |
| 136 | EPHA3 | 0.35744315 |
| 137 | NLK | 0.35664811 |
| 138 | WEE1 | 0.35144702 |
| 139 | TYK2 | 0.34777026 |
| 140 | FER | 0.34724054 |
| 141 | CAMK2A | 0.34574478 |
| 142 | GRK5 | 0.34308593 |
| 143 | BRAF | 0.34102383 |
| 144 | RPS6KA5 | 0.32361510 |
| 145 | CSNK2A1 | 0.31283152 |
| 146 | PAK6 | 0.30981956 |
| 147 | MAPK13 | 0.30245795 |
| 148 | PRKACG | 0.30197842 |
| 149 | LYN | 0.29529313 |
| 150 | ACVR1B | 0.29300339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.80566732 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.35062640 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.19834546 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.12594845 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.07120615 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.91395938 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.54169913 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.44009641 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28382089 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26073871 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.24588385 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.19537156 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.18957853 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.14916891 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13250406 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09823891 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 2.09346086 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.06266060 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.05733889 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.97662869 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.92750224 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91722075 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.88469322 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75251773 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68746125 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68627848 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68051166 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64658945 |
| 29 | Ribosome_Homo sapiens_hsa03010 | 1.62969815 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59825214 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.58254118 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.56749704 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.45548495 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45433595 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41034097 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.41021345 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40113257 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38567256 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38503955 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37316819 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.36712829 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35890973 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.35045428 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33715933 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32099299 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31843863 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30878000 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29365387 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26306088 |
| 50 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.22307900 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17937802 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16722021 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 1.13950433 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10520297 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10434908 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09911028 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.09806318 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08953547 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05228796 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05131984 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.97411361 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96655718 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94896229 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92664924 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92524243 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91736530 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89153410 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87541675 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87107192 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85771440 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83279738 |
| 72 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82231548 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.82120062 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80216706 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78544673 |
| 76 | Spliceosome_Homo sapiens_hsa03040 | 0.76606632 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76298785 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75995175 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75328687 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73398071 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72524699 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72105835 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.72031139 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.70274136 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70225144 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67888530 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67266479 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64987381 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64560474 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64429362 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63409906 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62761179 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.62236953 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59375372 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58909109 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58278718 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58095827 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56372647 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55078584 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.54958633 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51662404 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49563397 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.48656950 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.48630414 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46970090 |
| 106 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46658896 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45820615 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.44477183 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.43881128 |
| 110 | DNA replication_Homo sapiens_hsa03030 | 0.40584014 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39929728 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.37899951 |
| 113 | Mismatch repair_Homo sapiens_hsa03430 | 0.37835052 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35008569 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32991282 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32020456 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31693366 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30952684 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.30490968 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.30401316 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29000252 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24897304 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23569486 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23319273 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22471377 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22243138 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17384313 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.16393579 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16361875 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13807836 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.12665656 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.12643606 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.12570333 |
| 134 | Homologous recombination_Homo sapiens_hsa03440 | 0.12547642 |

